title: The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?
authors.forename: Alessio
authors.initials: A
authors.lastname: Aghemo
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Rumi
authors.forename: Gian Maria
authors.initials: GM
authors.lastname: Prati
authors.forename: Massimo
authors.initials: M
authors.lastname: Colombo
mesh_terms: D004305:Dose-Response Relationship, Drug; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D012254:Ribavirin